Crescent Biopharma, Inc.
USD17.98
+0.97 (+5.73%)
CEO
Joshua T. Brumm
IPO Date
2014-01-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.13
Prev. Close
$17.00
Day Low
$16.91
Day High
$17.98
52W Low
$8.72
52W High
$27.41
Market Cap
$0.50B
Volume
0.14M
| 5,000 |
| $0.00 |
| 17 Dec 2025 | Pinkas Jan | Chief Scientific Officer | A-Award | Acquired | 70,025 | $13.21 |
| 17 Dec 2025 | Doughty Christopher Grant | Chief Business Officer | A-Award | Acquired | 14,714 | $0.00 |
| 17 Dec 2025 | Doughty Christopher Grant | Chief Business Officer | A-Award | Acquired | 8,000 | $0.00 |
| 17 Dec 2025 | Doughty Christopher Grant | Chief Business Officer | A-Award | Acquired | 58,855 | $13.21 |
| 17 Dec 2025 | Brumm Joshua T | director, officer: Chief Executive Officer | A-Award | Acquired | 45,117 | $0.00 |
| 17 Dec 2025 | Brumm Joshua T | director, officer: Chief Executive Officer | A-Award | Acquired | 10,000 | $0.00 |
| 17 Dec 2025 | Brumm Joshua T | director, officer: Chief Executive Officer | A-Award | Acquired | 180,467 | $13.21 |
| 17 Dec 2025 | Scalzo Richard William | Chief Financial Officer | A-Award | Acquired | 14,422 | $0.00 |